Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Methods. We conducted a retrospective cohort study of IBD patients who were prescribed anti-TNF therapy (2007–2014) in Ontario. We assessed if the insurance type...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2017-01-01
|
| coleção: | Canadian Journal of Gastroenterology and Hepatology |
| Acesso em linha: | http://dx.doi.org/10.1155/2017/7365937 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|